Patel, Radhika
Barker, Holly E.
Kyula, Joan
McLaughlin, Martin
Dillon, Magnus T.
Schick, Ulrike
Hafsi, Hind
Thompson, Alan
Khoo, Vincent
Harrington, Kevin
Zaidi, Shane
Funding for this research was provided by:
ICR/RM NIHR Biomedical Research Centre
Oracle Cancer Trust
The Rosetree Trust
The Anthony Long Trust
CRUK (C7224/A13407)
Royal Marsden Hospital
This article is maintained by: Elsevier
Article Title: An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation
Journal Title: Radiotherapy and Oncology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.radonc.2016.12.026
Content Type: article
Copyright: © 2017 The Author(s). Published by Elsevier Ireland Ltd.